Chilton Capital Management’s Boston Scientific BSX Stock Holding History

Chilton Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.86K	Sell	67 -122	-65%	-$6.63K	﹤0.01%	526
2026 Q1	$11.9K	Buy	189 +162	+600%	+$13K	﹤0.01%	456
2025 Q4	$2.58K	Buy	+27	New	+$2.65K	﹤0.01%	532
2024 Q4	–	Sell	-114	Closed	-$9.55K	–	569
2024 Q3	$9.55K	Hold	114	–	–	﹤0.01%	488
2024 Q2	$8.78K	Buy	114 +29	+34%	+$2.12K	﹤0.01%	494
2024 Q1	$5.82K	Buy	+85	New	+$5.46K	﹤0.01%	505
2023 Q2	–	Sell	-3,150	Closed	-$158K	–	546
2023 Q1	$158K	Buy	+3,150	New	+$148K	0.01%	240
2022 Q3	–	Sell	-202	Closed	-$8K	–	263
2022 Q2	$8K	Buy	+202	New	+$8.22K	﹤0.01%	487
2022 Q1	–	Sell	-202	Closed	-$9K	–	273
2021 Q4	$9K	Buy	+202	New	+$8.49K	﹤0.01%	506

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Chilton Capital Management's BSX Position: Q2 2026 in Review

Chilton Capital Management reduced its Boston Scientific (BSX) stake by 65% in Q2 2026, selling an estimated $6.63K and leaving 67 shares worth $2.86K. The position accounts for ﹤0.01% of the portfolio, ranked #526.

Chilton Capital Management first reported a position in BSX in Q4 2021 and has held it in 9 quarters since. The position peaked at $158K in Q1 2023. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Chilton Capital Management held 67 shares of Boston Scientific worth $2.86K as of Q2 2026.
Chilton Capital Management sold 122 Boston Scientific shares in Q2 2026, an estimated $6.63K.
Boston Scientific made up ﹤0.01% of Chilton Capital Management's portfolio in Q2 2026, its #526 holding.
Chilton Capital Management first reported a position in Boston Scientific in Q4 2021 and has held it in 9 quarters since.
Chilton Capital Management's Boston Scientific position peaked at $158K in Q1 2023.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.